Anaergia (ANRG) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
22 May, 2026Business overview and strategy
Operates in 18+ countries with over 230 RNG facilities and 1,750+ technology installations, leveraging a capital-light, vertically integrated model.
Provides end-to-end solutions for converting organic waste into renewable natural gas, clean water, and fertilizer, with proprietary technology and in-house manufacturing in Germany, Italy, and Canada.
Focuses on capital sales, long-term service contracts, and build-own-operate (BOO) assets, generating diversified and recurring revenue streams.
Strategic partnerships and a leaner cost structure have strengthened the balance sheet and expanded the geographic footprint.
Technology and innovation
Holds approximately 300 active and pending patents, covering digestion, gas upgrading, and water treatment.
Proprietary technologies like OREX® and Omnivore® enable efficient extraction and digestion of organics, reducing capex and increasing system capacity.
Manufactures precision-engineered equipment for maximum biogas yield and resource recovery, embedding operational experience into product design.
Dual R&D platform drives both disruptive innovation and continuous improvements, supporting global commercial deployment.
Market opportunity and regulatory drivers
Global organic waste generation is projected to reach 3.86 billion tonnes by 2050, with only 6% currently treated.
Regulatory mandates in North America and Europe, such as California SB 1383 and the EU Landfill Directive, are driving demand for new RNG infrastructure.
Over $13B in new RNG infrastructure is required in California by 2030, and $78B in Europe to meet ambitious targets.
Asia presents significant growth opportunities due to high organic content in waste and emerging offtake markets.
Latest events from Anaergia
- Q3 2025 delivered 77% revenue growth, positive adjusted EBITDA, and a $287M backlog.ANRG
Q3 202527 May 2026 - Improved EBITDA, equity investment, and global expansion drive a more stable, profitable outlook.ANRG
Q3 202427 May 2026 - Revenue up 36.8%, gross margin at 32.5%, and backlog up 137%, supporting strong growth momentum.ANRG
Q2 202527 May 2026 - Revenue backlog hit $200M, up 94%, with improved losses and major contract wins.ANRG
Q1 202527 May 2026 - Improved margins, reduced losses, and a $103.3M backlog support strong 2025 growth.ANRG
Q4 202427 May 2026 - Revenue up 122% year-over-year, backlog at $265 million, and positive Adjusted EBITDA.ANRG
Q1 202617 May 2026 - Revenue fell 45% but gross margin and adjusted EBITDA improved as losses narrowed sharply.ANRG
Q2 202420 Apr 2026 - Rapid revenue growth and global expansion driven by proprietary RNG technology and regulatory demand.ANRG
Investor presentation7 Apr 2026 - Record revenue growth, positive EBITDA, and a 149% increase in backlog signal robust prospects.ANRG
Q4 202529 Mar 2026